Mineralys Therapeutics, Inc. Common Stock (NASDAQ: MLYS) last traded at $22.23, down 4.88% on the session. The quote above updates while this page is open; the figures below are drawn from Mineralys Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Mineralys Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MLYS. Its market capitalisation is $1.97 billion.
Valuation measures for Mineralys Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.97B |
|---|---|
| Enterprise value | $1.94B |
| Price / book | 3.57 |
| Beta | 1.31 |
Trailing-twelve-month figures tagged in Mineralys Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$349.58M |
| EPS (TTM) | -$4.16 |
|---|
| Return on equity | -63.45% |
|---|
| Cash | $138.27M |
|---|
Range and volume for MLYS over the past 52 weeks.
| 52-week high | $47.65 |
|---|---|
| 52-week low | $21.46 |
| Volume | 1.00M |
| Average volume | 1.04M |
| Previous close | $23.37 |
Invest a chosen dollar amount in Mineralys Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MLYS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.